Ensuring Clonality by Single-Cell Dispensing in Cell Line Development - 6PM London
Sponsored by: cytena GmbH
- Single Cells
- Cell Line Development
Date: 14 December
Time: 6PM London / 7PM Berlin / 1PM New York
proven | viable | pure
Ensuring clonality in cell line development is gaining more and more importance and attention by regulatory authorities. Additionally, high cell viability and the prevention of cross-contamination are necessary for successfully generating a high number of clones.
This webinar will illustrate a new technology for automatically isolating single cells: the single-cell printer. It can be used for all common cell types used in cell line development and helps you to meet your requirements, especially achieving a very high rate of clonal recovery.
What this webinar will cover:
- A new technology for isolating single cells
- Working principle
- Performance data
This webinar will be run twice at the following times:
- 9AM London / 10AM Berlin
- 6PM London / 7PM Berlin / 1PM New York
Please register for the time most relevant for you.
Jonas Schoendube (M.Sc.),
CEO cytena GmbH
Jonas Schoendube holds a B.Sc. in Mechanical Engineering and a M.Sc. in Micro and Nano Systems from ETH Zurich. He performed his Master's thesis at Stanford University, USA. He is expert in micro-fluidics, micro-fabrication and single-cell isolation.
Jonas and his colleague Andre Gross developed the single-cell printing technology.
Working with customers in the pharmaceutical industry, Jonas is very familiar with issues of evidence of clonality, cross-contamination and cell viability in cell culture.
Key Learning Objectives
- New technology for isolating single cells
- How to ensure clonality
- How to achieve high clonal recovery rates
- How to prevent cross contamination
- Head of Cell Line Development
- Director of Cell Line Development
- Research Associate Cell Line Development
- Project Managers
- C Levels
- Lab Manager
- Lab Leader
- Senior Scientist